Chairs: Dr. Janice Gibson and Dr. Surabhi Nanda

09:00-09:30 - The Coroner’s guidance and what it means for us? – Dr Tracey Johnston and Ms. Jayne Fisher
09:30-10:10 - Prenatal treatment of congenital disease - Prof Anna David
10:10-11:10 - Presentation of Abstracts: Fetal Medicine

The incremental yield of prenatal exome sequencing over chromosome microarray for congenital cardiac anomalies – a systematic review and meta-analysis. Kelly Reilly. Centre for Public Health, Queen’s University Belfast, UK
Design of a Phase 3 Study (AZALEA) of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN). R.Katie Morris. Institute of Applied Health Research, University of Birmingham, UK
The Use of Folic Acid Supplementation for the Prevention of Non Neural Tube Midline Congenital Abnormalities: a Systematic Review and Meta-analysis of 2,293,021 mothers. Grace Westland. University of Birmingham, UK
Plasma metabolomic and lipidomic profiles accurately classify mothers of children with congenital heart disease: a case control study. Stuart Mires. University of Bristol, UK
Prenatal Exome Sequencing for pregnancies with Fetal Anomalies – 3 year experience of diagnoses. Stephanie Allen. Birmingham Women’s & Children’s NHS Foundation Trust, UK

Agenda